From the Journals

AI and Diabetes: Promise and Precaution

The growing ability of AI systems “to influence human biology and lifespan might have implications we are not yet able to grasp."

Share

Artificial intelligence (AI) is advancing rapidly in diabetes care, providing tools for diagnosis, monitoring, and treatment while raising concerns about safety and ethics, as outlined by Stefan R. Bornstein, MD, and colleagues. AI applications such as insulin pumps and continuous glucose monitoring are already enhancing patient care. Future AI systems may identify at-risk individuals earlier through large datasets, particularly benefiting low-resource areas. However, careful oversight and regulatory frameworks are essential, considering privacy risks and the necessity of human involvement in decision-making.

Original Source(s)

AI and Diabetes: Promise and Precaution

The growing ability of AI systems “to influence human biology and lifespan might have implications we are not yet able to grasp."

  • by Doug Brunk

  • February 25, 2026

  • 3 min

Related Content

Can AI Predict Preterm Birth in Diabetic, Hypertensive Pregnancies?

Retrospective study finds machine-learning model identifies clinical factors associated with preterm delivery in a high-risk obstetric population.

FDA Approves New Option in Obesity

The Allurion Gastric Balloon System is now authorized by the US Food and Drug Administration for short-term weight loss in adults aged 22 to 65 years with obesity and a body mass index of 30 to 40 kg/m2.

Lifestyle Interventions vs Gestational Diabetes

Investigators report that lifestyle interventions during pregnancy reduce gestational diabetes risk, with effects varying by diagnostic criteria and maternal education level.